Wells Fargo & Company Issues Pessimistic Forecast for Kezar Life Sciences (NASDAQ:KZR) Stock Price
Kezar Life Sciences (NASDAQ:KZR – Free Report) had its price target lowered by Wells Fargo & Company from $20.00 to $11.00 in a research note released on Thursday,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock. KZR has been the topic of a number of other reports. William Blair […]
More Stories
MultiMetaVerse Holdings Limited (NASDAQ:MMV) Short Interest Down 18.3% in October
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) was the recipient of a large decrease in short interest during the...
Short Interest in Gentherm Incorporated (NASDAQ:THRM) Decreases By 18.7%
Gentherm Incorporated (NASDAQ:THRM – Get Free Report) was the target of a significant decline in short interest during the month...
Zillow Group, Inc. (NASDAQ:ZG) General Counsel Sells $134,813.38 in Stock
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) General Counsel Bradley D. Owens sold 1,846 shares of the company’s stock...
Short Interest in TruGolf Holdings, Inc. (NASDAQ:TRUG) Drops By 19.0%
TruGolf Holdings, Inc. (NASDAQ:TRUG – Get Free Report) was the recipient of a large drop in short interest in October....
Aspira Women’s Health Inc. (NASDAQ:AWH) Short Interest Update
Aspira Women’s Health Inc. (NASDAQ:AWH – Get Free Report) was the target of a significant growth in short interest in...
Beneficient (NASDAQ:BENFW) Short Interest Up 23.3% in October
Beneficient (NASDAQ:BENFW – Get Free Report) was the recipient of a large growth in short interest during the month of...